epilepsy

Biotech

Kriya buys Redpin to chart gene therapy course in neurology

Kriya is buying up Redpin Therapeutics for an undisclosed amount, an initial building block for the North Carolina biotech's neurology ambitions.
Max Bayer Nov 16, 2022 11:51am

Biohaven fuels up for post-Pfizer future with $302M

Nov 9, 2022 9:55am

New gene therapy for epilepsy hits seizures where they start

Nov 4, 2022 11:05am

Biohaven veers toward Kv7 platform following Pfizer sale

Oct 4, 2022 11:48am

FDA clears Seer Medical’s at-home epilepsy monitoring system

Sep 26, 2022 10:50am

Precisis nabs CE mark for 'brain pacemaker' to treat epilepsy

Sep 23, 2022 11:00am